Former Blackrock exec builds out team for new fund

Braven, an early stage firm focused on large, regulated sectors, this week named former FDA official Dr Sean Khozin as senior life sciences and healthcare partner.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.